152 related articles for article (PubMed ID: 35465837)
21. Nucleosome Assembly Protein 1-Like 3 Enhances Cisplatin Resistance of Ovarian Cancer Cell by Activating Transforming Growth Factor-Beta Pathway.
Mo X; Sun J; Xu L; Zhao N; Yan M; Li H; Qin P
J Interferon Cytokine Res; 2020 Jul; 40(7):333-340. PubMed ID: 32701410
[TBL] [Abstract][Full Text] [Related]
22. TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.
Yeung TL; Leung CS; Wong KK; Samimi G; Thompson MS; Liu J; Zaid TM; Ghosh S; Birrer MJ; Mok SC
Cancer Res; 2013 Aug; 73(16):5016-28. PubMed ID: 23824740
[TBL] [Abstract][Full Text] [Related]
23. microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition.
Parikh A; Lee C; Joseph P; Marchini S; Baccarini A; Kolev V; Romualdi C; Fruscio R; Shah H; Wang F; Mullokandov G; Fishman D; D'Incalci M; Rahaman J; Kalir T; Redline RW; Brown BD; Narla G; DiFeo A
Nat Commun; 2014; 5():2977. PubMed ID: 24394555
[TBL] [Abstract][Full Text] [Related]
24. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma.
Eichhorn PJ; Rodón L; Gonzàlez-Juncà A; Dirac A; Gili M; Martínez-Sáez E; Aura C; Barba I; Peg V; Prat A; Cuartas I; Jimenez J; García-Dorado D; Sahuquillo J; Bernards R; Baselga J; Seoane J
Nat Med; 2012 Feb; 18(3):429-35. PubMed ID: 22344298
[TBL] [Abstract][Full Text] [Related]
25. Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-β/Smad signaling pathway.
Geng J; Fan J; Ouyang Q; Zhang X; Zhang X; Yu J; Xu Z; Li Q; Yao X; Liu X; Zheng J
Oncotarget; 2014 Jul; 5(14):5700-11. PubMed ID: 25026293
[TBL] [Abstract][Full Text] [Related]
26. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
Vo BT; Cody B; Cao Y; Khan SA
Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
[TBL] [Abstract][Full Text] [Related]
27. TCEA3 binds to TGF-beta receptor I and induces Smad-independent, JNK-dependent apoptosis in ovarian cancer cells.
Cha Y; Kim DK; Hyun J; Kim SJ; Park KS
Cell Signal; 2013 May; 25(5):1245-51. PubMed ID: 23357533
[TBL] [Abstract][Full Text] [Related]
28. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
[TBL] [Abstract][Full Text] [Related]
30. Itraconazole inhibits invasion and migration of pancreatic cancer cells by suppressing TGF-β/SMAD2/3 signaling.
Chen K; Cheng L; Qian W; Jiang Z; Sun L; Zhao Y; Zhou Y; Zhao L; Wang P; Duan W; Ma Q; Yang W
Oncol Rep; 2018 Apr; 39(4):1573-1582. PubMed ID: 29484419
[TBL] [Abstract][Full Text] [Related]
31. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling.
Ding ZY; Jin GN; Liang HF; Wang W; Chen WX; Datta PK; Zhang MZ; Zhang B; Chen XP
Cell Signal; 2013 Oct; 25(10):1981-92. PubMed ID: 23727026
[TBL] [Abstract][Full Text] [Related]
33. Induction of ΔNp63 by the newly identified keratinocyte-specific transforming growth factor β Signaling Pathway with Smad2 and IκB Kinase α in squamous cell carcinoma.
Fukunishi N; Katoh I; Tomimori Y; Tsukinoki K; Hata R; Nakao A; Ikawa Y; Kurata S
Neoplasia; 2010 Dec; 12(12):969-79. PubMed ID: 21170261
[TBL] [Abstract][Full Text] [Related]
34. Crk-like adapter protein is required for TGF-β-induced AKT and ERK-signaling pathway in epithelial ovarian carcinomas.
Cheng S; Guo J; Yang Q; Han L
Tumour Biol; 2015 Feb; 36(2):915-9. PubMed ID: 25307974
[TBL] [Abstract][Full Text] [Related]
35. Aggregatibacter actinomycetemcomitans outer membrane protein 29 (Omp29) induces TGF-β-regulated apoptosis signal in human gingival epithelial cells via fibronectin/integrinβ1/FAK cascade.
Yoshimoto T; Fujita T; Kajiya M; Ouhara K; Matsuda S; Komatsuzawa H; Shiba H; Kurihara H
Cell Microbiol; 2016 Dec; 18(12):1723-1738. PubMed ID: 27121139
[TBL] [Abstract][Full Text] [Related]
36. Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad signaling pathway.
Peng H; Shintani S; Kim Y; Wong DT
Neoplasia; 2006 Dec; 8(12):1028-36. PubMed ID: 17217620
[TBL] [Abstract][Full Text] [Related]
37. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.
Grzmil M; Morin P; Lino MM; Merlo A; Frank S; Wang Y; Moncayo G; Hemmings BA
Cancer Res; 2011 Mar; 71(6):2392-402. PubMed ID: 21406405
[TBL] [Abstract][Full Text] [Related]
38. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P
Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874
[TBL] [Abstract][Full Text] [Related]
39. [Functional study on TGF-beta/Smads signaling pathway in human ovarian cancer cells].
Zhang YY; Li X; Sui LH; Wang Q; Li P; Fu SB
Yi Chuan Xue Bao; 2004 Aug; 31(8):759-65. PubMed ID: 15481528
[TBL] [Abstract][Full Text] [Related]
40. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
